Disorders: SSRIs, SNRIs,
Benzodiazepines, Buspirone,
Mechanisms of Action,
Pharmacokinetics, Clinical Indications,
Adverse Effects, Contraindications, and
Evidence-Based Therapeutic Strategies
Verified Questions Complete with A+
Graded RATIONALES LATEST UPDATED
2026
Antidepressants (SSRIs/SNRIs)
first line pharmacological agents for Anxiety
-Alternative Antidepressants
-Benzodiazepines
second line pharmacological agents for Anxiety
Benzodiazepines (BZDs)
• Facilitates inhibitory actions of GABA-A
• Binds allosteric site on postsynaptic GABA-A receptor- chloride ion channels
• Receptor between α and γ subunits
• ↑'s frequency of chloride channel opening
• Counteracts excitatory neurotransmitters
Ceiling Effect
Describes how:
-BZDs only work in presence of GABA
• Can inhibit GABA release
Benzodiazepines
1|Page
, Indications:
-anxiety disorder (short term)
-Short term use in panic disorders
-Hyponosis, anesthesia
-Anticonvulsant
-Decrease muscle spasms
-EtOH Withdrawal
Diazepam and Clorazepate
What are some highly lipophilic BZDs that are rapidly absorbed and cross the BBB?
Hydrophilic
Several BZDs highly metabolized in liver into _______________ metabolites
Long
Chlordiazepoxide & diazepam → __________-acting active metabolites
Short
Alprazolam, midazolam, & triazolam → ________-acting active metabolites
-Lorazepam
-Oxazepam
-Temazepam
(LOT)
-BZDs with no active metabolites ("out the liver")
-Preferred in the elderly
Short-Acting Benzodiazepines
-Midazolam
-Triazolam
Intermediate-Acting Benzodiazepines
-Alprazolam
-Lorazepam
-Oxazepam
Long-Acting Benzodiazepines
2|Page